Literature DB >> 25066532

Seizure threshold and the half-age method in bilateral electroconvulsive therapy in Japanese patients.

Kazuyuki Yasuda1, Kaoru Kobayashi, Masayasu Yamaguchi, Koichi Tanaka, Tomokazu Fujii, Yuichi Kitahara, Toshio Tamaoki, Yutaka Matsushita, Akihiko Nunomura, Nobutaka Motohashi.   

Abstract

AIM: Seizure threshold (ST) in electroconvulsive therapy (ECT) has not been reported previously in Japanese patients. We investigated ST in bilateral ECT in Japanese patients using the dose-titration method. The associations between demographic and clinical characteristics and ST were analyzed to identify the predictors of ST. Finally, the validity of the half-age method for the stimulus dose was evaluated.
METHODS: Fifty-four Japanese patients with mood disorder, schizophrenia, and other psychotic disorders received an acute course of bilateral ECT using a brief-pulse device. ST was determined at the first session using a fixed titration schedule. ST was correlated with age, sex, body mass index, history of previous ECT, and psychotropic drugs on multiple regression analysis. Furthermore, the rate of accomplished seizures was calculated using the half-age method.
RESULTS: Mean ST was 136 mC. ST was influenced by age, sex, history of previous ECT, and medication with benzodiazepines. The accomplished seizure rate using the half-age method was 72%, which was significantly lower in men and subjects on benzodiazepines.
CONCLUSION: ST in Japanese patients was equal to or slightly higher than that previously reported in other ethnic groups, which might be attributable, at least in part, to high prevalence of and large-dose benzodiazepine prescription. Higher age, male gender, no history of ECT, and benzodiazepines were related to higher ST. The half-age method was especially useful in female patients and subjects without benzodiazepine medication.
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  Japanese; dosing strategy; electroconvulsive therapy; race; seizure threshold

Mesh:

Substances:

Year:  2014        PMID: 25066532     DOI: 10.1111/pcn.12225

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  Effects of Psychotropic Drugs on Seizure Threshold during Electroconvulsive Therapy.

Authors:  Su-Hyuk Chi; Hyun-Ghang Jeong; Suji Lee; So-Young Oh; Seung-Hyun Kim
Journal:  Psychiatry Investig       Date:  2017-09-11       Impact factor: 2.505

2.  Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy.

Authors:  Sung Woo Joo; Yeon Ho Joo; Chang Yoon Kim; Jung Sun Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-29       Impact factor: 2.570

3.  Initial Seizure Threshold in Brief-Pulse Bilateral Electroconvulsive Therapy in Patients with Schizophrenia or Schizoaffective Disorder.

Authors:  Seong Hoon Jeong; Tak Youn; Younsuk Lee; Jin Hyeok Jang; Young Wook Jeong; Yong Sik Kim; In Won Chung
Journal:  Psychiatry Investig       Date:  2019-08-21       Impact factor: 2.505

4.  Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study.

Authors:  Wei Zheng; Qiaomei Cen; Sha Nie; Minyi Li; Rong Zeng; Sumiao Zhou; Dongbin Cai; Miaoling Jiang; Xiong Huang
Journal:  PeerJ       Date:  2021-02-05       Impact factor: 2.984

5.  Effect of age and anticonvulsants on seizure threshold during bilateral electroconvulsive therapy with brief-pulse stimulus: A chart-based analysis.

Authors:  Abhishek R Nitturkar; Preeti Sinha; Virupakshappa I Bagewadi; Jagadisha Thirthalli
Journal:  Indian J Psychiatry       Date:  2016 Apr-Jun       Impact factor: 1.759

6.  Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients.

Authors:  Pichai Ittasakul; Apichaya Likitnukul; Umporn Pitidhrammabhorn; Punjaporn Waleeprakhon; Morris B Goldman
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-07       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.